Latest news with #ShailyEngineeringPlastics
Time of India
28-07-2025
- Business
- Time of India
Maker of GLP1 pens scales up for generic debuts
As weight-loss drug sales surge with semaglutide's patent expiration, Gujarat's Shaily Engineering Plastics, an injector pen manufacturer, anticipates significant growth. Its stock has nearly doubled, and the company is doubling its production capacity to 80-85 million pens by fiscal year-end to meet rising domestic and export demands. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mumbai: With sales of weight-loss drugs surging and set to go up even more as semaglutide goes off patent early next year, a low-profile manufacturer of injector pens, Gujarat-based Shaily Engineering Plastics , is set to reap a windfall. Its stock has nearly doubled over the past 12 months. Manufacturers of the pen-like devices that make it easy to self-administer metered doses that would otherwise need to be injected with a syringe are the unnoticed beneficiaries of weight-loss drugs becoming is doubling capacity in line with plans of top pharma companies to launch generic versions of GLP1 weight-loss drugs early next year in India and overseas, said a senior company executive. It will be increasing capacity to 80-85 million pens by this fiscal year end from 40-45 million currently to cater to domestic and export demand, Sanjay Shah, chief strategy officer, told ET."We will look at further expansion and ramp up (in FY27). Currently, we are working with multiple players who are looking to launch generic semaglutide in different markets," he to Shah, various estimates suggest global demand for injector pens is likely to reach 500 million per year in the next two-three years and about 2 billion by is leading industry insiders to predict a looming supply crunch for pen leading drugmakers like Sun Pharma , Dr Reddy's, Cipla and Lupin are expected to be a part of the first-day launch wave in several international markets and India as soon as the patent is investing about '125 crore in FY26 on capacity expansion of its IP-led pen platform."We will be expanding (capacity) going forward to cater to the global as well as domestic market," said drugmaker Novo Nordisk 's weight-loss molecule semaglutide, branded Ozempic and Wegovy , will go off patent in March next year, opening up the gates for Indian and overseas drugmakers to launch cheaper generic expect an immediate price reduction of 50% and further by 60-80% over the coming years. This will boost affordability, potentially spurring sales of the drug and consequently, injector the past, shortages of both Eli Lilly's tirzepatide and Novo's semaglutide in the US were largely due to lack of devices and fill-n-finish capacities after demand for the drugs far outstripped supply.
&w=3840&q=100)
Business Standard
14-07-2025
- Business
- Business Standard
Ashish Kacholia portfolio stock hits record high; zooms 118% from March low
Share price of Faze Three Shares of Faze Three hit a record high of ₹694, soaring 7 per cent on the BSE in Monday's intra-day trade in an otherwise weak market. The stock price of the smallcap textile company surpassed its previous high of ₹667 touched on May 19, 2025. In comparison, the BSE Sensex was down 0.48 per cent at 82,107 at 02:38 PM. In the past two trading days, the stock surged 14 per cent. The market price of Faze Three has more-than-doubled or zoomed 118 per cent from its 52-week low of ₹318 touched on March 3, 2025 on the BSE. Ashish Kacholia hold 5 per cent stake in Faze Three Investor Ashish Kacholia held 1.32 equity shares representing 5.42 per cent stake in Faze Three at the end of March 2025 quarter, the shareholding pattern data showed. The ace investor - Ashish Kacholia reportedly holds over 1 per cent stake in other stocks such as in Shaily Engineering Plastics, Safari Industries, Tanfac Industries, Man Industries and Balu Forge. What's driving the Faze Three stock price? As global supply chains undergo realignment, India is rapidly emerging as a preferred textile manufacturing destination. With a skilled workforce, strong infrastructure, and rising investment in sustainability and innovation, India is well-equipped to meet global demands. Home textiles are the third largest segment of Indian textile industry after apparels and technical textiles. Bed linen and bath linen are the two largest selling products and together account for two-third of home textile market. Kitchen linens, curtains, upholstery, and rugs / carpets are the other major products in the sector. The landmark Free Trade Agreement (FTA) between India and the United Kingdom is poised to significantly boost India's textile exports to the UK, according to ICRA. India's apparel and home textiles trade with the UK is projected to double in the next 5-6 years, with export volumes expected to grow at a compounded annual rate of ~13 per cent. The UK's share in India's textile exports is anticipated to rise from 7-8 per cent to 11-13 per cent by CY2027, the rating agency said. The agreement is set to be operational in CY2026, pending legal review, marking a transformative milestone for India's textile sector and bilateral trade with the UK. Faze Three - Outlook Faze Three's major customers include global big-box retailers in the US, the UK, and Europe such as Walmart, Costco, Target, and Sainsbury, among others. The company benefits from established and long-term relationships with key customers, which are expected to result in high repeat orders and increasing wallet share, supporting revenue visibility, according to analysts. China plus one has been reinvigorated after a hiatus of 2 years. Almost all top retailers have targets of diversifying at least 15-20 per cent out of China within next 2-3 years if India / Others can deliver. Faze Three in FY25 investor presentation said that the company estimates revenue growth of at least 22-25 per cent for FY 26 and FY 27 given the build up and efforts undertaken over the last 2 years to expand product categories and growth across existing customers & categories while adding new customers too. The company caters to the high end home textiles segment and the orders are custom made as per the client specifications. Majority of the revenue (~90 per cent FY2023-24) is derived from the international market. The key export markets include the United States of America (USA), United Kingdom (UK), Germany, Australia, Hong Kong, Canada, South Africa, Brazil and others.
Mint
02-06-2025
- Business
- Mint
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 2 June 2025
Breakout stocks buy or sell: The Indian stock market posted losses for the second straight week following a U.S. court's decision to reinstate wide-ranging tariffs from the Trump era. Over the week, the Sensex fell by 270.07 points, or 0.33%, while the Nifty slipped 102.45 points, or 0.41%. The markets closed the week on a cautious note, reflecting investor wariness amid persistent global trade tensions and uncertainty over upcoming domestic policy decisions. Sumeet Bagadia, Executive Director at Choice Broking, believes that the undertone for the Indian stock market is positive but the Nifty 50 index is facing hurdle at 25,000 levels. Speaking on the outlook of Indian stock market, Bagadia said, ' On breaching above this resistance, we can expect the benchmark index to touch 25,400 soon. On the lower side, the index has made strong support at 24,500 levels. So, one should maintain stock-specific approach and look at those stocks that are looking strong on the technical chart. Looking at breakout stocks can be a good option." Sumeet Bagadia recommends five shares to buy today — R R Kabel, Sudarshan Chemical Industries, Shaily Engineering Plastics, Wockhardt, and Prudent Corporate Advisory Services. 1] R R Kabel: Buy at ₹ 1438, target ₹ 1540, stop loss ₹ 1385; 2] Sudarshan Chemical Industries: Buy at ₹ 1170, target ₹ 1250, stop loss ₹ 1125; 3] Shaily Engineering Plastics: Buy at ₹ 2016.8, target ₹ 2150, stop loss ₹ 1950; 4] Wockhardt: Buy at ₹ 1465.3, target ₹ 1560, stop loss ₹ 1410; 5] Prudent Corporate Advisory Services: Buy at ₹ 2952.7, target ₹ 3170, stop loss ₹ 2850. Disclaimer: The views and recommendations provided in this analysis are those of individual analysts or broking companies, not Mint. We strongly advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and individual circumstances may vary.
Business Standard
14-05-2025
- Business
- Business Standard
Shaily Engineering Plastics consolidated net profit rises 47.83% in the March 2025 quarter
Sales rise 27.71% to Rs 217.83 crore Net profit of Shaily Engineering Plastics rose 47.83% to Rs 28.59 crore in the quarter ended March 2025 as against Rs 19.34 crore during the previous quarter ended March 2024. Sales rose 27.71% to Rs 217.83 crore in the quarter ended March 2025 as against Rs 170.56 crore during the previous quarter ended March 2024. For the full year,net profit rose 62.54% to Rs 93.12 crore in the year ended March 2025 as against Rs 57.29 crore during the previous year ended March 2024. Sales rose 22.20% to Rs 786.80 crore in the year ended March 2025 as against Rs 643.87 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 217.83170.56 28 786.80643.87 22 OPM % 25.0220.34 - 22.3818.16 - PBDT 50.7131.57 61 161.43105.54 53 PBT 39.6021.57 84 119.2869.85 71 NP 28.5919.34 48 93.1257.29 63
